Published in Plant Physiol on December 01, 1980
Purification and measurement of abscisic Acid and indoleacetic Acid by high performance liquid chromatography. Plant Physiol (1986) 2.11
Estimation of Free, Conjugated, and Diffusible Indole-3-acetic Acid in Etiolated Maize Shoots by the Indolo-alpha-pyrone Fluorescence Method. Plant Physiol (1982) 1.73
Simultaneous quantitation of indole 3-acetic Acid and abscisic Acid in small samples of plant tissue by gas chromatography/mass spectrometry/selected ion monitoring. Plant Physiol (1987) 1.60
Sources of Free IAA in the Mesocotyl of Etiolated Maize Seedlings. Plant Physiol (1982) 1.55
The Rice COLEOPTILE PHOTOTROPISM1 gene encoding an ortholog of Arabidopsis NPH3 is required for phototropism of coleoptiles and lateral translocation of auxin. Plant Cell (2004) 1.20
Nature and Amount of Auxin in Algae : IAA from Extracts of Caulerpa paspaloides (Siphonales). Plant Physiol (1985) 1.01
Isolation of indole-3-acetic acid from corn kernels & etiolated corn seedlings. Plant Physiol (1961) 8.68
Isolation of 4-chloroindolyl-3-acetic acid from immature seeds of Pisum sativum. Nature (1968) 2.34
Indole-3-acetic Acid Levels of Plant Tissue as Determined by a New High Performance Liquid Chromatographic Method. Plant Physiol (1978) 2.07
Some chemical and physiological properties of 3-indolylpyruvic acid. Biochem J (1956) 2.03
Determination of submicrogram levels of indole-3-acetic acid: a new, highly specific method. Anal Biochem (1970) 1.98
Indole-3-acetic Acid in Douglas Fir: Analysis by Gas-Liquid Chromatography and Mass Spectrometry. Plant Physiol (1976) 1.39
Chromatography of a new natural auxin, 4-chloroindolyl-3-acetic acid and related chloro derivatives. Anal Biochem (1971) 0.98
Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol (1996) 2.33
Ageing in the whole plant. Symp Soc Exp Biol (1967) 1.75
Estimation of Free, Conjugated, and Diffusible Indole-3-acetic Acid in Etiolated Maize Shoots by the Indolo-alpha-pyrone Fluorescence Method. Plant Physiol (1982) 1.73
Sources of Free IAA in the Mesocotyl of Etiolated Maize Seedlings. Plant Physiol (1982) 1.55
Mechanisms of herpes simplex virus type 1 reactivation. J Virol (1996) 1.49
Herd prevalence and geographic distribution of, and risk factors for, bovine paratuberculosis in Wisconsin. J Am Vet Med Assoc (1994) 1.29
Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Res (1999) 1.28
Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. Virology (1997) 1.24
Functional role and sequence analysis of a lymphocyte orphan opioid receptor. J Neuroimmunol (1995) 1.10
The sequence of steps in the attachment of 5-S RNA to cores of Escherichia coli ribosomes. Biochim Biophys Acta (1973) 1.08
The inherent quantitative capacity of the reverse transcription-polymerase chain reaction. Anal Biochem (1999) 1.06
Innate and acquired immunity to herpes simplex virus type 1. Virology (1997) 1.00
An antibody to a peptide specified by an RNA that is complementary to gamma-endorphin mRNA recognizes an opiate receptor. J Neuroimmunol (1986) 1.00
Evaluation of conventional and radiometric fecal culture and a commercial DNA probe for diagnosis of Mycobacterium paratuberculosis infections in cattle. Can J Vet Res (1992) 0.99
A repository of specimens for comparison of diagnostic testing procedures for bovine paratuberculosis. J Vet Diagn Invest (1992) 0.97
Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J Immunol (1999) 0.95
Treatment of poor placentation and the prevention of associated adverse outcomes--what does the future hold? Prenat Diagn (2014) 0.92
Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. J Immunol (1998) 0.91
Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia. J Neuroimmunol (1999) 0.91
The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice. J Immunol (2001) 0.90
The structural basis for functional inactivity of reconstituted 50-S ribosomal subunits of Escherichia coli. Biochim Biophys Acta (1973) 0.89
Plasmid DNA encoding IFN-alpha 1 antagonizes herpes simplex virus type 1 ocular infection through CD4+ and CD8+ T lymphocytes. J Immunol (2000) 0.87
Forensic evidence in apparel fabrics due to stab events. Forensic Sci Int (2009) 0.87
Bidirectional communication between the neuroendocrine and immune systems. Common hormones and hormone receptors. Ann N Y Acad Sci (1990) 0.86
Aberrant regulation of cytokines in HIV-1 TAT72-transgenic mice. J Immunol (1996) 0.83
Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-beta is more potent than IFN-alpha 2. Virology (2001) 0.83
The relationship between interleukin-6 and herpes simplex virus type 1: implications for behavior and immunopathology. Brain Behav Immun (1999) 0.82
Thrombotic thrombocytopenic purpura associated with metastatic gastric adenocarcinoma: successful management with plasmapheresis. South Med J (1986) 0.82
Effects of flooding the root system of sunflower plants on the cytokin in content in the xylem sap. Physiol Plant (1969) 0.82
Topical application of the cornea post-infection with plasmid DNA encoding interferon-alpha1 but not recombinant interferon-alphaA reduces herpes simplex virus type 1-induced mortality in mice. J Neuroimmunol (2001) 0.82
Androstenediol antagonizes herpes simplex virus type 1-induced encephalitis through the augmentation of type I IFN production. J Immunol (1998) 0.81
Isolation, properties, and structure of fraction I protein from Avena sativa L. Planta (1968) 0.81
Identifying the source of bullet wipe: a randomised blind trial. Int J Legal Med (2013) 0.80
Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection. Curr Eye Res (2000) 0.80
A simple method for the preparation of 5S RNA from Escherichia coli. Hoppe Seylers Z Physiol Chem (1973) 0.80
Injury to recreational and professional cricket players: circumstances, type and potential for intervention. Accid Anal Prev (2010) 0.80
Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option? Immunol Res (2001) 0.80
Morphine reduces mortality in mice following ocular infection with HSV-1. Immunopharmacology (1999) 0.80
Gunshot induced indirect femoral fracture: mechanism of injury and fracture morphology. J R Army Med Corps (2013) 0.79
Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity. Int J Immunopharmacol (1994) 0.79
ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-alpha1 transgene efficacy. Virology (2001) 0.79
Enhancement of the generation of cytotoxic T cells by endogenous opiates. J Neuroimmunol (1986) 0.78
Cytokines and endotoxin removal by sorbents and its application in push-pull sorbent-based pheresis: the BioLogic-DTPF System. Artif Organs (1999) 0.78
Immunization with HSV-1 antigen rapidly protects against HSV-1-induced encephalitis and is IFN-gamma independent. J Interferon Cytokine Res (1998) 0.78
Clinical trials of the BioLogic-HD. Automated single access, sorbent-based dialysis. ASAIO Trans (1987) 0.77
Push-pull sorbent-based pheresis and hemodiabsorption in the treatment of hepatic failure: preliminary results of a clinical trial with the BioLogic-DTPF System. Ther Apher (2000) 0.77
IFN-alpha1 plasmid construct affords protection against HSV-1 infection in transfected L929 fibroblasts. J Interferon Cytokine Res (2000) 0.77
An antibody directed against a peptide encoded by RNA complementary to mRNA for vasopressin recognizes putative vasopressin receptors. Neuroendocrinology (1990) 0.76
A plasmid construct encoding murine interferon beta antagonizes the replication of herpes simplex virus type I in vitro and in vivo. J Neuroimmunol (2000) 0.76
Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). Int J Artif Organs (1992) 0.76
Interactions of human immunodeficiency virus type 1 transactivator of transcription protein with signal transduction pathways. Adv Neuroimmunol (1995) 0.76
Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice. Immunopharmacology (1995) 0.76
Subversion of intracellular signal transduction by herpes simplex virus type 1. Adv Neuroimmunol (1995) 0.76
Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen. Brain Behav Immun (1994) 0.76
Treatment of systemic inflammatory response syndrome by push-pull powdered sorbent pheresis: a Phase 1 clinical trial. Ther Apher (2001) 0.76
Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycin. Cancer (1984) 0.75
Activity of arildone with or without interferon against acute hemorrhagic conjunctivitis viruses in cell culture. Antimicrob Agents Chemother (1985) 0.75
Fentanyl-related 4-heteroanilido piperidine OHM3295 augments splenic natural killer activity and induces analgesia through opioid receptor pathways. J Pharmacol Exp Ther (1995) 0.75
Pretibial injury: key factors and their use in developing laboratory test methods. Int J Low Extrem Wounds (2008) 0.75
Doppler ultrasonic detection of particulate release during hemodialysis with cellulose hollow-fiber and sorbent suspension reciprocating dialyzers. Artif Organs (1984) 0.75
Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity. Int J Immunopharmacol (1995) 0.75
Studies on the abscission of blue lupin leaves : II. effects of kinetin and light on pulvinar and other types of explants. Planta (1967) 0.75
Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis. ASAIO Trans (1992) 0.75
Neuroendocrine peptide receptors on cells of the immune system. Chem Immunol (1997) 0.75
Effect of laundering on visible damage to apparel fabric caused by sharp force impact. Forensic Sci Int (2013) 0.75
[Isolation, purification and renaturation of recombinant-DNA-derived porcine somatotropin]. Sheng Wu Gong Cheng Xue Bao (2001) 0.75
Automatic priming, blood flow control, and rinsing during single access hemodialysis: the BioLogic-HD. Trans Am Soc Artif Intern Organs (1985) 0.75
Push-pull sorbent based pheresis for treatment of acute hepatic failure: the BioLogic-detoxifier/plasma filter System. ASAIO J (1998) 0.75
Effect of sorbent-based dialytic therapy with the BioLogic-DT on an experimental model of hepatic failure. ASAIO J (1994) 0.75
Comparative studies on mitochondrial development in yeasts. 3. Growth-phasic effects of antibiotics on mitochondrial differentiation in Candida. Cytobios (1974) 0.75
Tearing of knicker fabrics. Forensic Sci Int (2011) 0.75
Push-pull sorbent-based pheresis treatment in an experimental canine endotoxemia model: preliminary report. Int J Artif Organs (1999) 0.75
Helicopter main rotor blade injury to the head with survival. J R Army Med Corps (1997) 0.75
Physical and mechanical degradation of shirting fabrics in burial conditions. Forensic Sci Int (2012) 0.75
Effects of a dwarfing compound, CCC, on the production and export of gibberellin-like substances by root systems. Planta (1967) 0.75
A comparative evaluation of three neonatal ventilators. Crit Care Med (1986) 0.75
Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner. J Pharmacol Exp Ther (1996) 0.75
Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes. J Immunol (1993) 0.75
Effect of laundering on blunt force impact damage in fabrics. Forensic Sci Int (2010) 0.75
Actinomycin D and the hormonal induction of amylase synthesis in barley aleurone layers. Planta (1972) 0.75
Systemic inflammatory response syndrome treatment by powdered sorbent pheresis: the BioLogic-Detoxification Plasma Filtration System. ASAIO J (1999) 0.75